In summary, this study indicates that highly expressed USP1 is a promising target for CRC chemotherapies, especially when combined with therapeutics that directly act on cellular DNA, and provides the therapeutic target for CRC in the future. The gene discussed is USP1; the disease is colorectal carcinoma.